Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC patients may benefit from liver transplantation, hepatic resection, radiofrequency ablation, transcatheter arterial chemoembolization, and targeted therapies. The increased infiltration of immunosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasano, Rossella, Shadbad, Mahdi Abdoli, Brunetti, Oronzo, Argentiero, Antonella, Calabrese, Angela, Nardulli, Patrizia, Calbi, Roberto, Baradaran, Behzad, Silvestris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704694/
https://www.ncbi.nlm.nih.gov/pubmed/34947886
http://dx.doi.org/10.3390/life11121355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704694/
https://www.ncbi.nlm.nih.gov/pubmed/34947886
http://dx.doi.org/10.3390/life11121355

Ejemplares similares